Astellas Pharma (4503N) Q1 2023 Earnings Report
MX:4503N Q1 2023 EPS Results
- Actual EPS
- MXN 2.17
- Consensus EPS
- MXN 3.51
- Beat/Miss
- Missed by -MXN 1.34
- One Year Ago EPS
- MXN 1.60
MX:4503N Q1 2023 Revenue Results
- Actual Revenue
- MXN 44.12B
- Expected Revenue
- MXN 42.55B
- Beat/Miss
- Beat by +MXN 1.57B
- YoY Revenue Growth
- -1.78%
Earnings Announcement Details
- Quarter
- Q1 2023
- Date
- 08/01/2023
- Time
- Before Open
- Conference Call
- Tuesday, August 1, 2023
MX:4503N Upcoming Earnings
Astellas Pharma's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q1 2023 Earnings Call Audio
MX:4503N Q1 2023 Earnings Call
0:00 / 0:00
Q1 2023 Earnings Slide Deck
Q1 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4503N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q2) | 7.65- | 5.2 | ― | ― |
| Aug 05, 2026 | 2026 (Q1) | 6.379.31 | 4.5 | 107.09% (+4.82) | |
| Apr 27, 2026 | 2025 (Q4) | 3.602.86 | 4.92 | -41.95% (-2.06) | |
| Feb 04, 2026 | 2025 (Q3) | 5.406.59 | -6.42 | 202.73% (+13.01) | |
| Oct 30, 2025 | 2025 (Q2) | 3.515.20 | 2.36 | 120.44% (+2.84) | |
| Jul 30, 2025 | 2025 (Q1) | 2.344.50 | 2.47 | 82.00% (+2.03) | |
| Apr 25, 2025 | 2024 (Q4) | 2.514.92 | -2.18 | 325.50% (+7.11) | |
| Feb 04, 2025 | 2024 (Q3) | 2.89-6.42 | 1.22 | -624.52% (-7.64) | |
| Oct 30, 2024 | 2024 (Q2) | 2.122.36 | -0.09 | 2607.50% (+2.45) | |
| Aug 01, 2024 | 2024 (Q1) | 1.122.47 | 2.17 | 13.76% (+0.30) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
